Page last updated: 2024-08-24

fluorodeoxyglucose f18 and Cavernous Angioma, Central Nervous System

fluorodeoxyglucose f18 has been researched along with Cavernous Angioma, Central Nervous System in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Healy, GM; Killeen, RP; Kinsella, J; Redmond, CE1
Kawabe, T; Mineura, K; Miyamoto, J; Owada, K; Sasajima, H; Tatsuzawa, K1

Trials

1 trial(s) available for fluorodeoxyglucose f18 and Cavernous Angioma, Central Nervous System

ArticleYear
Usefulness and limitations of fluorine-18-fluorodeoxyglucose positron emission tomography for the detection of malignancy of orbital tumors.
    Neurologia medico-chirurgica, 2008, Volume: 48, Issue:11

    Topics: Adenocarcinoma; Adolescent; Adult; Aged; Astrocytoma; Carcinoma, Adenoid Cystic; Diagnosis, Differential; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Glioblastoma; Hemangioma, Cavernous, Central Nervous System; Humans; Lymphoma, B-Cell, Marginal Zone; Male; Melanoma; Middle Aged; Neurilemmoma; Optic Nerve Neoplasms; Orbital Neoplasms; Orbital Pseudotumor; Positron-Emission Tomography; Radiopharmaceuticals; Young Adult

2008

Other Studies

1 other study(ies) available for fluorodeoxyglucose f18 and Cavernous Angioma, Central Nervous System

ArticleYear
PET imaging of subclinical seizure associated with intracranial cavernous malformations.
    QJM : monthly journal of the Association of Physicians, 2017, Volume: 110, Issue:1

    Topics: Epilepsies, Partial; Female; Fluorodeoxyglucose F18; Hemangioma, Cavernous, Central Nervous System; Humans; Magnetic Resonance Imaging; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals

2017